Did the AAP's clinical statement on lipid screening get it right?
DR. STETTLER is a member of the AAP's Committee on Nutrition and an assistant professor of pediatrics and epidemiology at the Children's Hospital of Philadelphia. Dr. Stettler was involved in a multicenter trial for dyslipidemia medications funded by Merck & Co. in 2000 and another by Pfizer Inc. in 2006 and has been a consultant for Wyeth Nutritional and the Dannon Institute.
PREVIEW
DR. STETTLER is a member of the AAP's Committee on Nutrition and an assistant professor of pediatrics and epidemiology at the Children's Hospital of Philadelphia. Dr. Stettler was involved in a multicenter trial for dyslipidemia medications funded by Merck & Co. in 2000 and another by Pfizer Inc. in 2006 and has been a consultant for Wyeth Nutritional and the Dannon Institute.